Related Experiment Video
Updated: May 8, 2026
08:02
Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Oxidative stress and bronchopulmonary dysplasia
Serafina Perrone1, Maria Luisa Tataranno, Giuseppe Buonocore
1Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Italy.
Journal of Clinical Neonatology
|September 13, 2013
Summary
Bronchopulmonary dysplasia (BPD) in infants is a significant lung disease. Oxidative stress and inflammation are key factors, and antioxidants may offer future treatment strategies for this condition.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Pediatric Critical Care
Background:
- Bronchopulmonary dysplasia (BPD) remains a primary cause of infant lung disease, despite advances in neonatal intensive care.
- BPD presents significant public health challenges, including high mortality, impaired growth, and neurodevelopmental issues.
- Multiple cumulative factors contribute to neonatal lung injury, including genetic, hemodynamic, metabolic, nutritional, mechanical, and infectious mechanisms.
Purpose of the Study:
- To review the pathophysiology of BPD, focusing on oxidative stress and inflammation.
- To discuss current management strategies aimed at reducing BPD incidence and severity.
- To explore future therapeutic avenues, particularly antioxidant supplementation.
Main Methods:
- Literature review and synthesis of existing research on BPD.
- Analysis of the role of free radical generation and oxidative stress in lung injury.
- Examination of the interplay between inflammation and oxidative stress in BPD pathogenesis.
Main Results:
- Oxidative stress, driven by free radical generation, is a central mechanism in BPD-related lung damage.
- Inflammatory placental disorders, chorioamnionitis, and airway inflammation contribute significantly to BPD.
- Individualized interventions focusing on ventilation, oxygen exposure, apnea, and growth are crucial for BPD management.
Conclusions:
- Antioxidant supplementation is a promising future strategy for preterm infants at risk of BPD.
- Further research is necessary to validate the efficacy of antioxidants in mitigating BPD.
- Optimizing neonatal care and exploring novel therapeutic targets are essential for addressing BPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: